| __timestamp | Bausch Health Companies Inc. | Vericel Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 21263000 |
| Thursday, January 1, 2015 | 582800000 | 18890000 |
| Friday, January 1, 2016 | 455000000 | 15295000 |
| Sunday, January 1, 2017 | 366000000 | 12944000 |
| Monday, January 1, 2018 | 414000000 | 13599000 |
| Tuesday, January 1, 2019 | 471000000 | 30391000 |
| Wednesday, January 1, 2020 | 452000000 | 13020000 |
| Friday, January 1, 2021 | 465000000 | 16287000 |
| Saturday, January 1, 2022 | 529000000 | 19943000 |
| Sunday, January 1, 2023 | 604000000 | 21042000 |
Unlocking the unknown
In the ever-evolving landscape of the healthcare industry, innovation is a key driver of success. This is evident when comparing the R&D spending of Bausch Health Companies Inc. and Vericel Corporation over the past decade. From 2014 to 2023, Bausch Health has consistently outpaced Vericel in research and development investments, with an average annual expenditure nearly 25 times greater. In 2023, Bausch Health's R&D spending reached its peak at approximately $604 million, marking a 145% increase from 2014. Meanwhile, Vericel's R&D expenses have shown a more modest growth, peaking at around $21 million in 2023. This disparity highlights Bausch Health's aggressive pursuit of innovation, while Vericel maintains a more conservative approach. As the healthcare sector continues to advance, these investment strategies will likely play a crucial role in shaping the future of both companies.
Who Prioritizes Innovation? R&D Spending Compared for BeiGene, Ltd. and Vericel Corporation
Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.: Strategic Focus on R&D Spending
Pharming Group N.V. or Bausch Health Companies Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for ADMA Biologics, Inc. and Bausch Health Companies Inc.
Comparing Innovation Spending: Ultragenyx Pharmaceutical Inc. and Vericel Corporation
Who Prioritizes Innovation? R&D Spending Compared for CRISPR Therapeutics AG and Vericel Corporation
Research and Development Investment: Amicus Therapeutics, Inc. vs Vericel Corporation
Research and Development Investment: Vericel Corporation vs MannKind Corporation
Analyzing R&D Budgets: Vericel Corporation vs Wave Life Sciences Ltd.
R&D Spending Showdown: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: Vericel Corporation and Xencor, Inc.